A practical reference on proteolysis: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-16 and is reviewed periodically as new material appears.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.
Most published work on selank originates from a small number of research groups in the Russian Federation. A large share of that record appears in Russian-language journals, which limits access for readers who rely on English-indexed databases. Independent replication by laboratories outside the original research network is sparse in publicly available sources. This concentration of origin and language is a frequently noted feature when the compound is summarized in broader reviews of synthetic peptides.
Quantification in biological matrices relies on liquid chromatography coupled to tandem mass spectrometry with stable-isotope internal standards. Low plasma concentrations and adsorption to container surfaces both complicate measurement. Solid-phase extraction is often needed to reduce matrix interference before injection. Reported limits of quantification differ widely between laboratories, which makes direct comparison of pharmacokinetic results difficult and limits meta-analysis.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Derived from the seven-residue sequence |
| Molecular weight | About 751.9 g/mol | Average mass; the monoisotopic value is slightly lower |
| Residue count | Seven amino acids | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Parent compound | Tuftsin (Thr-Lys-Pro-Arg) | Selank extends tuftsin at the C-terminus |
| Compound class | Synthetic short peptide | Studied in a research setting; not a licensed drug in most markets |
Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.
Handling follows standard practice for research peptides. Material is weighed in a low-humidity environment because the powder absorbs atmospheric moisture. Purity is reported as the percentage area of the main peak in a chromatogram, with specifications commonly set at 95 percent or higher; values below that threshold indicate the presence of truncated or modified species. Residual trifluoroacetate from purification is often present and may affect mass balance. Certificates of analysis should state the analytical method, the column and gradient used, and the lot-specific retention time so that results can be compared across suppliers.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
AOA1 is caused by biallelic mutation in APTX gene. Missense mutations (mutations that result in the change of amino acids in the specific location of the protein) usually result in much milder symptoms and delayed onset than truncating mutations. Founder effect was found in Japanese and Portuguese patients (V230fs and P206L are Japanese founder mutations; R199H and W279X are Portuguese founder mutations). Monoallelic variants, in rare cases, can produce phenotype similar to multiple system atrophy.
Catholic socialism was promoted by politicians such as Heinrich Mertens and Vitus Heller, as well as the Catholic priest Wilhelm Hohoff, who argued that Marx's criticism of capitalism is consistent with Catholic social teaching, and believed that the atheism of socialism "was not an essential ingredient but only a transient phase". The Catholic socialists of the Centre Party presented various positions, such as promoting a "third way" between capitalism and communism based on the papal encyclical Quadragesimo anno, or advocating economical socialism with a strongly religious and socially conservative character, but rejecting the secular currents of socialism and social democracy. In stark contrast to pro-parliamentary and pro-republican factions of the Centre, there were also anti-republican and anti-democratic factions, which argued that Weimar democracy promoted anti-Catholic values such as secularism, individualism and materialism. The party's right wing was represented by figures such as the cardinal Michael von Faulhaber or Hermann Port, who sought cooperation with conservative parties. Because of the extreme ideological heterogeneity of the party, it simultaneously participated in pro- and anti-republican coalitions on the local level. In attempt to solve internal dissent, the party would increasingly appoint Catholic priests and clerics to leading positions, as opposed to non-clerical politicians associated with certain interest groups within the party. This practice led to the appointment of figures such as Ludwig Kaas in 1928.
=== Antivenom === Until the advent of antivenom, bites from some species of snake were almost universally fatal. Despite huge advances in emergency therapy, antivenom is often still the only effective treatment for envenomation. The first antivenom was developed in 1895 by French physician Albert Calmette for the treatment of Indian cobra bites. Antivenom is made by injecting a small amount of venom into an animal (usually a horse or sheep) to initiate an immune system response. The resulting antibodies are then harvested from the animal's blood. Antivenom is injected into the person intravenously, and works by binding to and neutralizing venom enzymes. It cannot undo the damage already caused by venom, so antivenom treatment should be sought as soon as possible. Modern antivenoms are usually polyvalent, making them effective against the venom of numerous snake species. Pharmaceutical companies that produce antivenom target their products against the species native to a particular area. The availability of antivenom is a major concern in some areas, including most of Africa, due to economic reasons (antivenom crisis). In Sub-Saharan Africa, the efficacy of antivenom is often poorly characterised and some of the few available products have even been found to lack effectiveness. Although some people may develop serious adverse reactions to antivenom, such as anaphylaxis, in emergency situations this is usually treatable in a hospital setting and hence the benefit outweighs the potential consequences of not using antivenom.
Sources: en.wikipedia.org
Piracetam is not a vitamin, mineral, amino acid, herb or other botanical, or dietary substance for use by humans to supplement the diet by increasing the total dietary intake. Further, piracetam is not a concentrate, metabolite, constituent, extract or combination of any such dietary ingredient. [...] Accordingly, these products are drugs, under section 201(g)(1)(C) of the Act, 21 U.S.C. § 321(g)(1)(C), because they are not foods and they are intended to affect the structure or any function of the body. Moreover, these products are new drugs as defined by section 201(p) of the Act, 21 U.S.C. § 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling.
=== Advantages === Plants do not carry pathogens that might be dangerous to human health. Additionally, on the level of pharmacologically active proteins, there are no proteins in plants that are similar to human proteins. On the other hand, plants are still sufficiently closely related to animals and humans that they are able to correctly process and configure both animal and human proteins. Their seeds and fruits also provide sterile packaging containers for the valuable therapeutics and guarantee a certain storage life. Global demand for pharmaceuticals is at unprecedented levels. Expanding the existing microbial systems, although feasible for some therapeutic products, is not a satisfactory option on several grounds. Many proteins of interest are too complex to be made by microbial systems or by protein synthesis. These proteins are currently being produced in animal cell cultures, but the resulting product is often prohibitively expensive for many patients. For these reasons, science has been exploring other options for producing proteins of therapeutic value. These pharmaceutical crops could become extremely beneficial in developing countries. The World Health Organization estimates that nearly 3 million people die each year from vaccine preventable disease, mostly in Africa. Diseases such as measles and hepatitis lead to deaths in countries where the people cannot afford the high costs of vaccines, but pharm crops could help solve this problem.
From southern Scandinavia and northern Germany, the Germanic peoples expanded south, east, and west, coming into contact with the Celtic, Iranian, Baltic, and Slavic tribes. Southern Germany was inhabited by Celtic-speaking peoples, who belonged to the wider La Tène culture. They were later assimilated by the Germanic conquerors. Under Augustus, the Roman Empire began to invade lands inhabited by the Germanic tribes, creating a short-lived Roman province of Germania between the Rhine and Elbe rivers. In 9 AD, three Roman legions were defeated by Arminius in the Battle of the Teutoburg Forest. The outcome of this battle dissuaded the Romans from their ambition of conquering Germania and is thus considered one of the most significant events in European history. By 100 AD, when Tacitus wrote Germania, Germanic tribes had settled along the Rhine and the Danube (the Limes Germanicus), occupying most of modern Germany. However, Baden-Württemberg, southern Bavaria, southern Hesse and the western Rhineland had been incorporated into Roman provinces. Around 260, Germanic peoples broke into Roman-controlled lands. After the invasion of the Huns in 375, and with the decline of Rome from 395, Germanic tribes moved farther southwest: the Franks established the Frankish Kingdom and pushed east to subjugate Saxony and Bavaria. Areas of modern eastern Germany were inhabited by Western Slavic tribes.
==== Canada ==== After completing medical school, internists in Canada require an additional four years of training. Internists desiring to subspecialize are required to complete two additional years of training that may begin after the third year of internist training. The Royal College of Physicians and Surgeons of Canada (RCPSC) is a national non-profit agency that oversees and accredits medical education in Canada. A full medical license in Internal Medicine in Canada requires a medical degree, a license from the Medical Council of Canada, completion of the required post-graduate education, and certification from the RCPSC. Any additional requirements from separate medical regulatory authorities in each province or territory is also required. Internists may practice in Canada as generalists in Internal Medicine or serve in one of seventeen subspecialty areas. Internists may work in many settings including outpatient clinics, inpatient wards, critical care units, and emergency departments. The currently recognized subspecialties include the following:
Sources: en.wikipedia.org
In the late-1970s, Ruben Rausing worked on Operation Flood, a joint venture between the World Food Programme, the World Bank, and Tetra Pak to supply Western milk surplus to Indian households. The company established its Food for Development office in 2000, through which it works with local governments, NGOs and farmers to develop school milk programmes, a cause it has supported since 1962, when the first school milk programme supported by Tetra Pak launched in Mexico. After the 2008 Chinese melamine scandal, the Chinese government tightened regulations on safety and environmental standards, damaging the country's market for packaged milk and infant formula. Tetra Pak had nothing to do with the scandal; however, Tetra Pak China established a training program that was delivered by a food safety school, DVDs, and books, resulting in over 30 farms meeting EU quality standards, according to Tetra Pak China. The effort also included a push to reduce waste by advising customers on recycling and working alongside the World Wildlife Fund to reduce carbon dioxide emissions. The Financial Times indicated this was not a philanthropic act, but a way to establish a future for the company by ensuring there was always a market for their products. In 2015, Tetra Pak in collaboration with DeLavel, signed a five-year agreement with the Dairy Association of China to provide training to 150 Chinese dairy farm managers, providing them with the skills required to run larger-scale dairy farms. It is unclear if this initiative was voluntary or paid for.
=== Cochlear implants === NASA engineer Adam Kissiah started working in the mid-1970s on what became the cochlear implant, a surgically implanted device that allows people suffering from certain kinds of hearing loss, and who receive little or no benefit from traditional hearing aids. Inspired by his own hearing problems, Kissiah, an electronics instrumentation engineer at NASA, spent 3 years of lunches and evenings in Kennedy Space Center's technical library, studying how engineering principles could affect the inner ear. In 1977, NASA assisted Kissiah in obtaining a patent for the cochlear implant.
Tulip festivals are held around the world, for example in the Netherlands and Spalding, England. There is also a popular festival in Morges, Switzerland. Every spring, there are tulip festivals in North America, including the Tulip Time Festival in Holland, Michigan, the Skagit Valley Tulip Festival in Skagit Valley, Washington, the Tulip Time Festival in Orange City and Pella, Iowa, and the Canadian Tulip Festival in Ottawa, Ontario, Canada. Tulips are also popular in Australia and several festivals are held in September and October, during the Southern Hemisphere's spring. The Indira Gandhi Memorial Tulip Garden in India hosts an annual tulip festival which draws huge attention and has an attendance of over 200,000.
Sources: en.wikipedia.org
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, designed as a metabolically stabilized analogue of the endogenous tetrapeptide tuftsin. It has been studied mainly against anxiety-related and cognitive endpoints rather than as an approved medicine in most jurisdictions.
Tuftsin contains four residues, while selank carries an additional Pro-Gly-Pro segment at the carboxyl end. That extension is intended to reduce enzymatic cleavage. Comparative pharmacokinetic data in humans remain limited.
No single receptor target is widely accepted as the definitive mediator of the reported effects. Proposed contributors include GABAergic modulation, shifts in monoamine turnover, and altered neuropeptide degradation. The mechanism is treated in the literature as unresolved.
Dry powder is best kept sealed, protected from light, and held at minus 20 degrees Celsius or below. Desiccant packaging helps limit moisture uptake because the material is hygroscopic. A sealed vial should be allowed to equilibrate to room temperature before opening to reduce condensation.